Stratec Past Earnings Performance

Past criteria checks 1/6

Stratec's earnings have been declining at an average annual rate of -8.6%, while the Medical Equipment industry saw earnings growing at 1.9% annually. Revenues have been growing at an average rate of 2.6% per year. Stratec's return on equity is 4.4%, and it has net margins of 4%.

Key information

-8.6%

Earnings growth rate

-8.8%

EPS growth rate

Medical Equipment Industry Growth-9.5%
Revenue growth rate2.6%
Return on equity4.4%
Net Margin4.0%
Next Earnings Update27 Mar 2025

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Stratec makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

LSE:0RAR Revenue, expenses and earnings (EUR Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 24251103710
30 Jun 24256153410
31 Mar 2425212339
31 Dec 2326213329
30 Sep 2325512319
30 Jun 2326219327
31 Mar 2326019327
31 Dec 2227529307
30 Sep 2227028308
30 Jun 2226927299
31 Mar 2229140289
31 Dec 2128740289
30 Sep 2129646256
30 Jun 2128641266
31 Mar 2126635277
31 Dec 2025028288
30 Sep 20235242810
30 Jun 20225212810
31 Mar 2022417278
31 Dec 1921414268
30 Sep 19212142510
30 Jun 1920714259
31 Mar 19195112510
31 Dec 18188112410
30 Sep 1819316269
30 Jun 18197232610
31 Mar 18198242710
31 Dec 17207273110
30 Sep 1720828328
30 Jun 1720620338
31 Mar 1720319348
31 Dec 1618519298
30 Sep 16166142610
30 Jun 16155192210
31 Mar 1614421189
31 Dec 1514722188
30 Sep 1514722185
30 Jun 1514621175
31 Mar 1514521165
31 Dec 1414520175
30 Sep 1414219167
30 Jun 1413718166
31 Mar 1413216175
31 Dec 1312815165

Quality Earnings: 0RAR has high quality earnings.

Growing Profit Margin: 0RAR's current net profit margins (4%) are lower than last year (4.7%).


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: 0RAR's earnings have declined by 8.6% per year over the past 5 years.

Accelerating Growth: 0RAR's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: 0RAR had negative earnings growth (-16.8%) over the past year, making it difficult to compare to the Medical Equipment industry average (39.9%).


Return on Equity

High ROE: 0RAR's Return on Equity (4.4%) is considered low.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/23 22:07
End of Day Share Price 2024/12/23 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Stratec SE is covered by 20 analysts. 6 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Volker BraunBankhaus Lampe KG
Odysseas ManesiotisBerenberg
Scott BardoBerenberg